Issue 2/2018
Content (23 Articles)
Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer
Antti Silvoniemi, Sami Suilamo, Timo Laitinen, Sarita Forsback, Eliisa Löyttyniemi, Samuli Vaittinen, Virva Saunavaara, Olof Solin, Tove J. Grönroos, Heikki Minn
The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer
Ka-Rham Kim, Hyun-Jeong Shim, Jun-Eul Hwang, Sang-Hee Cho, Ik-Joo Chung, Ki Seong Park, Sae-Ryung Kang, Seong Young Kwon, Woong-Ki Chung, Woo Kyun Bae
Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study
Thiemo J. A. van Nijnatten, B. Goorts, S. Vöö, M. de Boer, L. F. S. Kooreman, E. M. Heuts, J. E. Wildberger, F. M. Mottaghy, M. B. I. Lobbes, M. L. Smidt
A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer
Antoine Schernberg, Sylvain Reuze, Fanny Orlhac, Irène Buvat, Laurent Dercle, Roger Sun, Elaine Limkin, Alexandre Escande, Christine Haie-Meder, Eric Deutsch, Cyrus Chargari, Charlotte Robert
Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer
Alexis Moscoso, Álvaro Ruibal, Inés Domínguez-Prado, Anxo Fernández-Ferreiro, Míchel Herranz, Luis Albaina, Sonia Argibay, Jesús Silva-Rodríguez, Juan Pardo-Montero, Pablo Aguiar
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery
Margarita Kirienko, Luca Cozzi, Lidija Antunovic, Lisa Lozza, Antonella Fogliata, Emanuele Voulaz, Alexia Rossi, Arturo Chiti, Martina Sollini
The prognostic value of 18F–FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastases
Harald Grut, Svein Dueland, Pål Dag Line, Mona Elisabeth Revheim
68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans
Mike Sathekge, Thabo Lengana, Alex Maes, Mariza Vorster, JanRijn Zeevaart, Ismaheel Lawal, Thomas Ebenhan, Christophe Van de Wiele
68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making
B. Grubmüller, P. Baltzer, D. D’Andrea, S. Korn, A. R. Haug, M. Hacker, K. H. Grubmüller, G. M. Goldner, W. Wadsak, S. Pfaff, J. Babich, C. Seitz, H. Fajkovic, M. Susani, P. Mazal, G. Kramer, S. F. Shariat, Markus Hartenbach
Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
Kambiz Rahbar, Martin Bögeman, Anna Yordanova, Maria Eveslage, Michael Schäfers, Markus Essler, Hojjat Ahmadzadehfar
Could 68Ga-somatostatin analogues be an important alternative to 18F-DOPA PET/CT in pediatrics?
Arnoldo Piccardo, Giorgio Treglia
18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation
Charlotte Dahl Christiansen, Henrik Petersen, Anne Lerberg Nielsen, Sönke Detlefsen, Klaus Brusgaard, Lars Rasmussen, Maria Melikyan, Klas Ekström, Evgenia Globa, Annett Helleskov Rasmussen, Claus Hovendal, Henrik Thybo Christesen
Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
Sue Ping Thang, Mei Sim Lung, Grace Kong, Michael S. Hofman, Jason Callahan, Michael Michael, Rodney J. Hicks
Quantitative 18F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype
Vincent Amodru, Carole Guerin, Sarkis Delcourt, Pauline Romanet, Anderson Loundou, Bruna Viana, Thierry Brue, Frédéric Castinetti, Frédéric Sebag, Karel Pacak, David Taïeb
Patterns of bone tracer uptake on SPECT-CT in symptomatic and asymptomatic patients with primary total hip arthroplasty
Thierry Schweizer, Filippo-Franco Schiapparelli, Niccolo Rotigliano, Helmut Rasch, Felix Amsler, Michael T. Hirschmann
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials
Ruth Ladenstein, Bieke Lambert, Ulrike Pötschger, Maria-Rita Castellani, Valerie Lewington, Zvi Bar-Sever, Aurore Oudoux, Anna Śliwińska, Katerina Taborska, Lorenzo Biassoni, Gregory A. Yanik, Arlene Naranjo, Marguerite T. Parisi, Barry L. Shulkin, Helen Nadel, Michael J. Gelfand, Katherine K. Matthay, Julie R. Park, Susan G. Kreissman, Dominique Valteau-Couanet, Ariane Boubaker
Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F–FDG PET/CT in pediatric patients with neuroblastoma
Chao Li, Jian Zhang, Suyun Chen, Shuo Huang, Shuqi Wu, Linlin Zhang, Fengxian Zhang, Hui Wang
All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting
Sally F. Barrington, Tom Sulkin, Adam Forbes, Peter W. M. Johnson
On the 18F–fluoride PET imaging quantification to predict 223Ra-dichloride treatment response
Eric Laffon, Henri de Clermont, Roger Marthan, Fredéric Paycha
Klaus Bohndorf, Mark Anderson, Mark Davies, Herwig Imhof, Klaus Woertler: Imaging of bones and joints. A concise, multimodality approach
Andrea Genova, Luigi Mansi
Correction to: 18F-NaF PET/CT: EANM procedure guidelines for bone imaging
M. Beheshti, F. M. Mottaghy, F. Paycha, F. F. F. Behrendt, T. Van den Wyngaert, I. Fogelman, K. Strobel, M. Celli, S. Fanti, F. Giammarile, B. Krause, W. Langsteger
Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
Sue Ping Thang, Mei Sim Lung, Grace Kong, Michael S. Hofman, Jason Callahan, Michael Michael, Rodney J. Hicks